Hillsdale Investment Management’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-31,730
Closed -$67.6K – 673
2026
Q1
$67.6K Buy
+31,730
New +$61.6K ﹤0.01% 597
2024
Q4
– Sell
-38,480
Closed -$69.6K – 593
2024
Q3
$69.6K Buy
+38,480
New +$70.3K 0.01% 441

Other funds holding CGEN

Hillsdale Investment Management's CGEN Position: Q2 2026 in Review

Hillsdale Investment Management sold out of Compugen (CGEN) in Q2 2026, closing a stake of 31,730 shares — an estimated $67.6K sold.

Hillsdale Investment Management first reported a position in CGEN in Q3 2024 and held it in 2 quarters. The position peaked at $69.6K in Q3 2024. 83 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

  • Hillsdale Investment Management reported no remaining Compugen position as of Q2 2026 after selling out during the quarter.
  • Hillsdale Investment Management sold 31,730 Compugen shares in Q2 2026, an estimated $67.6K.
  • Hillsdale Investment Management first reported a position in Compugen in Q3 2024 and held it in 2 quarters.
  • Hillsdale Investment Management's Compugen position peaked at $69.6K in Q3 2024.
  • 83 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.